New Delhi : To enable a single-window clearance system in pharmaceuticals sector, the government will set up a high-level committee next week to work out the modalities for the same.
The committee will be headed by Pharmaceuticals Secretary V K Subburaj and the move follows a recommendation by the task force on enabling the private sector to lead the growth of the pharma sector.
“It (committee) will suggest a mechanism for single-window clearance for the pharmaceuticals industry,” Chemicals and Fertiliser Minister Ananth Kumar told PTI. He said key decision-making powers on various important aspects such “patents, licencing and pricing are with different departments”.
While the issue of patents is dealt by Department of Industrial Policy & Promotion, drug licence is given by Drug Controller General of India under Health Ministry and pricing is controlled by NPPA, under Pharmaceuticals Department. “This coordination committee will comprise members from all these departments,” Kumar said.
